Andre Bovell is currently the Director of Pharmacy, Prevention, Nutrition and Statistics at the Medical Benefits Scheme and organization solely devoted to managing eleven chronic noncommunicable diseases. He heads a small but talented team of some 45 persons who supports his job functions. He brings to his position a wealth of knowledge and experience in pharmaceutical manufacturing, pharmacy management, procurement and inventory management and epidemiology. He is presently the chairperson of the Medical Benefits Scheme’s Formulary Committee and a member of the Working Group for the Establishment of the National Cancer Registry. Andre holds qualifications in Pharmacy, Management, and Epidemiology. He is a graduate of the Universities of Guyana and the University of London, UK. Currently he is a PhD candidate at the University of KwaZulu-Natal, South Africa. His current research area focuses on the epidemiological and economic burden of four common cancers in Antigua and Barbuda. This work takes account of incidence, trends, patterns and survival analysis of female breast, cervical, colorectal and prostate cancers. It also provides current evidence on the economic burden of these diseases by way of a cost-of-illness analysis from the prevalence-based provider perspective. This work encompasses the period 2017-2021 and utilizes data abstracted from four key study sites in Antigua and Barbuda. Other research interests include work on ageing, diabetes epidemiology and infectious